Elevated interleukin-6 levels predict short-term flare in systemic lupus erythematosus - Summary - MDSpire

Elevated interleukin-6 levels predict short-term flare in systemic lupus erythematosus

  • By

  • Borja del Carmelo Gracia Tello

  • José Miguel García-Bruñén

  • Luis Corredor

  • Natalia Allue Fantova

  • Eva Ma Calvo Beguería

  • Rubén García-Muñío

  • Laura Pérez Abad

  • Jimena Aramburu Llorente

  • Beatriz Martinez Muriel

  • Paula Vidales Miguélez

  • Roxanna Alexandra Morante Mendoza

  • Julia Martínez Artigot

  • Noelia Chicano Nieto

  • Jorge Álvarez Troncoso

  • Luis Martinez-Lostao

  • Adela Marín Ballvé

  • May 8, 2026

  • 0 min

Share

Objective:

To investigate the predictive capacity of serum interleukin-6 (IL-6) levels for imminent disease flares in patients with systemic lupus erythematosus (SLE), highlighting the significance of early intervention.

Key Findings:
  • 48% of patients had IL-6 levels exceeding 5 pg/mL during follow-up, indicating a significant proportion at risk.
  • Higher IL-6 levels correlated with a significantly shorter time to the next flare (median 10 months less), emphasizing the urgency for monitoring.
  • Increased IL-6 levels predicted various manifestations including arthritis, nephritis, serositis, and hematologic symptoms, suggesting a broader clinical relevance.
  • IL-6 demonstrated superior discriminative capability compared to anti-dsDNA, C3, and C4, reinforcing its potential as a key biomarker.
Interpretation:

Elevated circulating IL-6 levels are indicative of imminent disease flares in SLE, suggesting its potential as a biomarker for monitoring disease activity and guiding treatment decisions.

Limitations:
  • Single-center study may limit generalizability and introduce selection bias.
  • Exclusion of patients with concurrent conditions affecting IL-6 levels may limit the applicability of findings.
Conclusion:

Increased IL-6 levels may enhance the predictive accuracy of existing biomarkers for short-term disease reactivation in SLE, underscoring the need for its integration into clinical monitoring strategies.

Original Source(s)

Elevated interleukin-6 levels predict short-term flare in systemic lupus erythematosus

  • by Borja del Carmelo Gracia Tello, José Miguel García-Bruñén, Luis Corredor, Natalia Allue Fantova, Eva Ma Calvo Beguería, Rubén García-Muñío, Laura Pérez Abad, Jimena Aramburu Llorente, Beatriz Martinez Muriel, Paula Vidales Miguélez, Roxanna Alexandra Morante Mendoza, Julia Martínez Artigot, Noelia Chicano Nieto, Jorge Álvarez Troncoso, Luis Martinez-Lostao, Adela Marín Ballvé

  • May 8, 2026

Related Content

Clinical characteristics and risk factors of protein-losing enteropathy: a retrospective study

BMI Patterns in ILD Outcomes Examined

Meta-analysis links higher body mass index to lower mortality and slower lung function decline in interstitial lung disease

Semaglutide Use Linked to Erythromelalgia Remission

Case details diagnostic workup and rapid symptom resolution following GLP-1 receptor agonist initiation.